5α-Reductase Inhibitors Impact Prognosis of Urothelial Carcinoma

September 2020 in “ BMC Cancer ”

Chien-Sheng Wang, Ching‐Chia Li, Yung‐Shun Juan, Wen‐Jeng Wu, Hsiang‐Ying Lee

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on bmccancer.biomedcentral.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors

20 citations , May 2018 in “The Journal of Urology”

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

research Finasteride Does Not Prevent Bladder Cancer: A Secondary Analysis of the Medical Therapy for Prostatic Symptoms Study

13 citations , May 2018 in “Urologic Oncology: Seminars and Original Investigations”

Finasteride does not prevent bladder cancer.

research Expression of AR, 5αR1 and 5αR2 in Bladder Urothelial Carcinoma and Relationship to Clinicopathological Factors

13 citations , September 2017 in “Life sciences”

Androgens may influence bladder cancer progression by affecting cellular behavior.